#ACR21 L10 TRAIL1: Pirfenidone for RA-ILD ⭐️Low pt enrollment due to pandemic, 1/2 of planned trial size ▶️ Unable to meet primary endpt (composite death+FVC) but met FVC markers. Most pronounced in UIP patterns on HRCT @Rheumnow https://t.co/HB7N9Wl9Dn https://t.co/muBEguAAja